895 studies found for:    Open Studies | "Prostatic Diseases"
Show Display Options
Rank Status Study
1 Recruiting Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
Conditions: Prostatic Hyperplasia, Benign;   Prostatic Hypertrophy, Benign;   Genital Diseases, Male;   Lower Urinary Tract Symptoms;   Prostatic Diseases
Interventions: Procedure: Prostatic Arterial Embolization;   Procedure: Sham procedure
2 Recruiting Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate Cancer
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Genital Diseases, Male;   Prostatic Diseases
Intervention: Drug: EPI-506
3 Not yet recruiting A Prospective Trial of Povidone-iodine Suppository Before Transrectal Ultrasound Guided Prostate Biopsy
Conditions: Infection;   Prostatic Diseases;   Misadventure During Aspirating Needle Biopsy
Intervention: Drug: Povidone-Iodine
4 Recruiting MRI for Assessment of Hypoxia-Induced Prostate Cancer Aggressiveness
Conditions: Prostatic Neoplasms;   Genital Neoplasms, Male;   Prostatic Diseases
Intervention:
5 Recruiting Molecular Studies and Clinical Correlations in Human Prostatic Disease
Condition: Prostate Cancer
Intervention:
6 Recruiting A JNJ-56021927 (ARN-509) QT/QTc Study
Condition: Castration-Resistant Prostate Cancer
Intervention: Drug: JNJ-56021927
7 Recruiting Phase 1-2 Study of Onapristone in Patients With Advanced Castration-resistant Prostate Cancer
Conditions: Prostate Cancer;   Metastatic Prostate Cancer;   Androgen-independent Prostate Cancer;   Recurrent Prostate Cancer
Interventions: Drug: onapristone;   Drug: abiraterone
8 Recruiting Radiotherapy vs Observation for CRPC
Condition: Hormone Refractory Prostate Cancer
Intervention:
9 Unknown  Efficacy and Safety Study of the Therapeutic Vaccine PEP223 in Prostate Cancer Patients
Condition: Prostate Cancer
Intervention: Biological: PEP-223/CoVaccine HT
10 Recruiting Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Conditions: Prostate Adenocarcinoma;   Stage II Prostate Adenocarcinoma;   Stage III Prostate Adenocarcinoma
Interventions: Radiation: 3-Dimensional Conformal Radiation Therapy;   Radiation: Intensity-Modulated Radiation Therapy;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration;   Radiation: Selective External Radiation Therapy
11 Not yet recruiting 68Ga-PSMA PET/CT in Detecting Prostate Cancer Recurrence in Patients With Elevated PSA After Initial Treatment
Conditions: Prostate Adenocarcinoma;   PSA Failure;   Recurrent Prostate Carcinoma
Interventions: Procedure: Computed Tomography;   Radiation: Gallium Ga 68-labeled PSMA Ligand Glu-urea-Lys(Ahx)-HBED-CC;   Other: Laboratory Biomarker Analysis;   Procedure: Positron Emission Tomography
12 Not yet recruiting Determinants of Quality Of Life in AGEd Cancer Patients
Conditions: Colorectal Neoplasms;   Prostatic Neoplasms
Intervention:
13 Not yet recruiting Engaging Newly Diagnosed Men About Cancer Treatment Options
Condition: Prostatic Neoplasms
Interventions: Other: Standard NCCN counseling;   Other: Standard NCCN counseling and Oncotype DX results
14 Not yet recruiting A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Leuprolide
15 Not yet recruiting Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability
Condition: Prostate Cancer
Intervention: Other: No Intervention
16 Not yet recruiting PET/MRI in Patients With Suspected Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: 68Ga- PSMA-HBED-CC;   Device: Biograph mMR, Siemens
17 Recruiting Abiraterone-Rechallenge Study for CRPC Patients
Condition: Prostate Cancer
Intervention: Drug: abiraterone acetate
18 Recruiting A Phase 4 Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Male Subjects With Overactive Bladder (OAB) Symptoms, While Taking the Alpha Blocker for Benign Prostatic Hypertrophy (BPH)
Condition: Overactive Bladder
Interventions: Drug: Mirabegron;   Drug: Placebo
19 Not yet recruiting Dose Escalating Study of Foxy-5 in Breast-, Colon- or Prostate Cancer Patients
Conditions: Metastatic Breast Cancer;   Metastatic Colon Cancer;   Metastatic Prostate Cancer
Intervention: Drug: Foxy-5
20 Recruiting Phase 1/1b Study to Evaluate the Safety and Tolerability of CPI-444 Alone and in Combination With Atezolizumab in Advanced Cancers
Conditions: Non-Small Cell Lung Cancer;   Malignant Melanoma;   Renal Cell Cancer;   Triple Negative Breast Cancer;   Prostate Cancer;   Head and Neck Cancer;   Colorectal Cancer;   Bladder Cancer
Interventions: Drug: CPI-444;   Drug: CPI-444 + atezolizumab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years